Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Hypoxia
Type
Interventional
Phase
Early Phase 1
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Following screening, six healthy adults will report to the Human Performance Clinical Research Laboratory on two separate occasions, each separated by ~7-14 days. During each visit, study participants will undergo physiological monitoring prior to and during inhalation of hypoxic (FiO2=0.15) gas mixtures. During one of these visits, following initiation of hypoxic gas breathing, colon administration of RMO will commence.Masking: None (Open Label)Masking Description: Open labelPrimary Purpose: Health Services Research

Participation Requirements

Age
Between 18 years and 40 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04870801
Collaborators
Respirogen Inc.
Investigators
Principal Investigator: Chris Bell, PhD CSU